Metrics
- Price
- $28.00
- Market Cap $M
- 1,364
- Rel Volume
- 0.77
- Vol Up 2W
- 44.4%
- Vol Trend 2W
- +64.8%
- 1D
- -0.6%
- 1W
- +1.4%
- 1M
- -6.0%
- 1M Slope
- -10.6%
- 6M Range
- 84.3%
- Score
- 76.6
- Sharp
- 0.0
Volume
Profile
UroGen Pharma develops and commercializes therapies for urothelial and specialty urology cancers and conditions, including bladder cancer treatments.
Biotech
Pharmaceuticals
Healthcare